-- CoreWeave（CRWV）は、2031年満期、利率9.75%のシニア債10億ドルの私募発行価格を決定した。 CoreWeaveは木曜日の声明で、この債券は額面価格の102%で発行され、特定の完全子会社が無担保優先債として保証すると発表した。 声明によると、この債券は、CoreWeaveが以前に発行した2031年満期、利率9.75%のシニア債17億5000万ドルの発行を規定した4月14日付の債券契約に基づき、追加発行される。 この私募は火曜日に完了する予定。 CoreWeaveは、調達資金を一般事業目的に充当する計画である。
Price: $117.69, Change: $-1.00, Percent Change: -0.84%
(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.
Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.
Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.